Categorynews

John Conway, Former Head of Data Sciences and AI at Astra Zeneca, Joins Riffyn as Chief Commercial Officer

June 20, 2019 Off By BusinessWire

A recognized scientific informatics pioneer, Mr. Conway brings to
Riffyn extensive experience transforming scientific data environments
and analytics

OAKLAND, Calif.–(BUSINESS WIRE)–Riffyn, a global provider of cloud software for scientific process
design and data analytics, announced today that John F. Conway, a
pioneer of advanced R&D data and informatics systems and platforms, has
joined the company as Chief Commercial Officer. In his new role, John
will lead Riffyn’s global expansion, align key partnerships, and drive
revenue growth as demand for the company’s services continues to
increase.

“John has worked intimately for three decades with life science,
material science, and chemical enterprises across the R&D lifecycle: as
a biopharma research scientist, as an executive informatics leader in
R&D IT, and as a vendor and consultant to the pharma industry,” said Tim
Gardner, Founder and CEO of Riffyn. “What enthuses me most is John’s
all-encompassing vision for the future of R&D informatics — an ecosystem
of applications that communicate on a shared data backbone to facilitate
global collaboration.”

While leading Astra Zeneca (MedImmune) R&D IT, John focused on
delivering major, advanced IT programs and scientific data management
initiatives to support disruptive scientific breakthroughs. Prior to
Astra Zeneca, John was Global Director of R&D Innovation and Thought
Leadership at Accenture and Global Director of Strategy at LabAnswer,
where he provided management consulting to CXOs and informatics leaders
who were looking for pragmatic and sustainable solutions for their
scientific data.

“I am thrilled to join Riffyn whose scientific development environment
has the ability to transform the way scientists interact within their
labs and how they use and reuse their data in a FAIR way,” said Mr.
Conway. “I’m looking forward to making a major impact at Riffyn, helping
the company to realize its potential to be the backbone of next
generation lab environments and collaborative R&D ecosystems.”

John has also worked as Vice President of Enterprise Scientific
Informatics services and Business Development at Schrodinger, and Global
Senior Director of Scientific Informatics and Services at Accelrys.
Within the lab, John worked as Director and Site Head of ChemInformatics
and Structural Biology Domain for GlaxoSmithKline and as Senior Analyst/
Scientific Programmer / Programmer Analyst / Biochemist at Merck.

About Riffyn (www.riffyn.com)

Riffyn’s pioneering software-as-a-service platform for scientific
experimentation solves previously intractable data fragmentation and
data sharing problems in R&D organizations. Using patented technology
based on “scientific blueprints”, Riffyn breaks down data silos to
provide deeply integrated data sets for real-time analysis and global
access. Riffyn supports eight of the top 15 global biopharmaceutical,
biotechnology, and food technology firms.